Markus Ollert Selected Research

Carcinogens

1/2018

The Role of Fibroblast Growth Factor-Binding Protein 1 in Skin Carcinogenesis and Inflammation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Markus Ollert Research Topics

Disease

45	Hypersensitivity (Allergy) 05/2024 - 07/2005
13	Asthma (Bronchial Asthma) 05/2024 - 08/2008
12	Anaphylaxis (Anaphylactic Shock) 01/2022 - 10/2004
11	COVID-19 10/2023 - 01/2020
10	Inflammation (Inflammations) 07/2022 - 09/2004
8	Atopic Dermatitis (Atopic Eczema) 01/2016 - 04/2007
6	Venom Hypersensitivity 01/2020 - 01/2010
5	Bites and Stings (Sting) 01/2020 - 04/2011
4	Allergic Rhinitis 05/2024 - 01/2020
4	Neoplasms (Cancer) 01/2022 - 08/2013
3	Food Hypersensitivity (Food Allergy) 10/2023 - 01/2020
3	Infections 07/2022 - 04/2011
2	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2023 - 09/2012
2	Peanut Hypersensitivity (Peanut Allergy) 12/2022 - 01/2020
2	red meat allergy 01/2022 - 01/2019
2	Autoimmune Diseases (Autoimmune Disease) 01/2017 - 08/2013
2	Eczema 12/2011 - 10/2008
2	Skin Diseases (Skin Disease) 01/2010 - 10/2008
1	Glioma (Gliomas) 01/2024
1	Rhinitis 01/2023
1	Glioblastoma (Glioblastoma Multiforme) 01/2023
1	Clinical Deterioration 11/2022
1	Breakthrough Infections 07/2022
1	Pathologic Processes 03/2021
1	Communicable Diseases (Infectious Diseases) 01/2021
1	Gynecomastia 10/2020
1	Opioid-Related Disorders (Opiate Addiction) 01/2020
1	Pain (Aches) 01/2020
1	Drug Hypersensitivity (Drug Allergy) 01/2020
1	Type 2 Diabetes Mellitus (MODY) 01/2018
1	ZAP70 deficiency 01/2018
1	Diabetes Mellitus 01/2018
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2018

Drug/Important Bio-Agent (IBA)

33	Immunoglobulin E (IgE)IBA 01/2024 - 05/2007
25	AllergensIBA 10/2023 - 07/2005
12	Arthropod VenomsIBA 10/2021 - 07/2005
10	Biomarkers (Surrogate Marker)IBA 05/2024 - 01/2018
7	VenomsIBA 11/2021 - 01/2010
5	Proteins (Proteins, Gene)FDA Link 12/2022 - 04/2011
4	CarbohydratesIBA 01/2022 - 01/2010
3	OvalbuminIBA 10/2023 - 01/2010
3	Antiviral Agents (Antivirals)IBA 01/2022 - 08/2008
3	VaccinesIBA 01/2021 - 11/2012
3	AntibodiesIBA 01/2019 - 05/2007
2	N-(2-cyanoethylene)urea (BA 1)IBA 10/2023 - 07/2022
2	Neutralizing AntibodiesIBA 10/2023 - 07/2022
2	CytokinesIBA 10/2023 - 11/2022
2	Wasp Venoms (Venom, Wasp)IBA 01/2022 - 07/2011
2	COVID-19 VaccinesIBA 10/2021 - 01/2021
2	Ethylnitrosourea (N-Ethyl-N-nitrosourea)IBA 01/2018 - 08/2013
2	Carrier Proteins (Binding Protein)IBA 01/2018 - 07/2011
2	Bee Venoms (Bee Venom)IBA 10/2017 - 12/2016
2	Glutathione (Reduced Glutathione)IBA 01/2017 - 01/2017
2	anti-IgE antibodiesIBA 05/2011 - 11/2007
2	Myeloblastin (Proteinase 3)IBA 07/2008 - 09/2004
1	NexusIBA 01/2024
1	N-methyl-valyl-amiclenomycin (BA 2)IBA 10/2023
1	Virulence Factors (Pathogenicity Factors)IBA 01/2023
1	Epidermal Growth Factor (EGF)IBA 11/2022
1	MicroRNAs (MicroRNA)IBA 11/2022
1	Interleukin-10 (Interleukin 10)IBA 11/2022
1	HydrogelsIBA 07/2022
1	Broadly Neutralizing AntibodiesIBA 07/2022
1	GlycolipidsIBA 01/2022
1	Glycoproteins (Glycoprotein)IBA 01/2022
1	EpitopesIBA 01/2022
1	Biotin (Vitamin H)FDA Link 01/2022
1	Immunoglobulin A (IgA)IBA 05/2021
1	ChemokinesIBA 03/2021
1	erucylphosphocholineIBA 01/2021
1	EndotoxinsIBA 01/2021
1	CPG-oligonucleotideIBA 01/2021
1	OligodeoxyribonucleotidesIBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	P-2 (P 2)IBA 01/2021
1	Oxygen (Dioxygen)IBA 11/2020
1	AndrogensIBA 10/2020
1	Estrogens (Estrogen)FDA Link 10/2020
1	Monoclonal AntibodiesIBA 01/2020
1	ProteomeIBA 01/2020
1	Opioid Analgesics (Opioids)IBA 01/2020
1	Opioid Peptides (Opioid Peptide)IBA 01/2020
1	Opioid Receptors (Opioid Receptor)IBA 01/2020
1	Peptides (Polypeptides)IBA 01/2020
1	ParvalbuminsIBA 01/2019
1	anthraceneIBA 01/2018
1	matrigelIBA 01/2018
1	Autophagy-Related ProteinsIBA 01/2018
1	Immune Checkpoint InhibitorsIBA 01/2018
1	Blood Glucose (Blood Sugar)IBA 01/2018
1	CarcinogensIBA 01/2018

Therapy/Procedure

10	Immunotherapy 01/2022 - 12/2016
9	Therapeutics 12/2021 - 04/2007
2	Precision Medicine 10/2022 - 01/2020
1	Radiotherapy 01/2022
1	Drug Therapy (Chemotherapy) 01/2022
1	Injections 10/2021
1	Artificial Heart (Artificial Hearts) 01/2021
1	Aftercare (After-Treatment) 01/2021
1	Contraindications 01/2021